Shilpa Medicare has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) on 24^th October 2019, for the Finished Dosage Formulation Facility.

Today is the last trading session of the Samvat 2075 and market participants would wish to bid adieu to it on a high note. However, all hopes to end this year with an explosive trading session seem quashed with the likely cautious opening of the market this morning, thanks to India’s growth being slashed by Fitch to 5.5 per cent for the current fiscal.

The zone of 11,500-11,550 level is a crucial support area and the level of 11,700-11,720 is a resistance zone. A sustainable move on either side would lead to a trending move. Stocks in news: Tata Steel, Power Grid, Chalet Hotels, Vodafone Idea.

Cadila Healthcare Limited's wholly owned subsidiary Liva Pharmaceuticals Ltd. has received USFDA approval for Haloperidol Decanoate Injection.

The following stocks would be in focus during Friday’s trading session in light of their results announcement: Jubilant Life Sciences , State Bank of India, Tata Motors, V2 Retail and HeidelbergCement India.

Key indices made optimistic start, as investors took some encouragement after India jumped 14 places to the 63rd position on the World Bank's ease of doing business ranking, riding high on the government's flagship Make in India scheme and other reforms attracting foreign investment.

Alembic Pharmaceuticals announced that its joint venture named Aleor Dermaceuticals received approval for Desonide Ointment, 0.05 per cent from USFDA.

Bharat Sanchar Nigam Limited (BSNL) sees this as a very important step from the government. According to the latest published financial numbers by the company, its net loss stood Rs. 8000 crore in fiscal 2018 while MTNL, for FY19, reported net loss of Rs. 3390 crore.

Aurobindo Pharma has informed the exchanges on receiving final approval from the US Food & Drug Administration (USFDA) for Guaifenesin tablets.